Articles, App Notes, Case Studies, & White Papers

  1. Investigational Medicinal Products: Labeling Changes And Their Implications 12/16/2022

    Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.

  2. Flexible Integrations To Reduce Risks And Increase Efficiencies 10/4/2024

    Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.

  3. How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs 1/1/2022

    When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.

  4. The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets 10/4/2024

    Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.

  5. Developing Injectable Drug Placebo Formulations For Clinical Trials 1/9/2024

    Developing a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.

  6. Navigate Complex Ancillary Supply Sourcing Challenges 8/1/2022

    Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain. 

  7. Key Considerations For Emerging Companies When Selecting Packaging Components

    Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.

  8. Managing Complex Global Drug Distribution And Expiry 1/12/2021

    A global top-ten pharma company sponsored a complex, 8-year Phase III trial across 43 countries. As costs mounted and supplies waned, it realized the trial could be better managed if outsourced. 

  9. Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology 11/20/2024

    Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.

  10. How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain 5/16/2025

    In an increasingly competitive and regulated landscape, the right ERP system is no longer optional—it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.